Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-22-001514
Filing Date
2022-02-17
Accepted
2022-02-17 16:16:51
Documents
1
Period of Report
2022-02-15

Document Format Files

Seq Description Document Type Size
1 form4-02172022_010238.html 4  
1 form4-02172022_010238.xml 4 4006
  Complete submission text file 0001415889-22-001514.txt   5496
Mailing Address ONE MAIN STREET, 10TH FLOOR CAMBRIDGE MA 02142
Business Address ONE MAIN STREET, 10TH FLOOR CAMBRIDGE MA 02142 617-417-5868
Black Diamond Therapeutics, Inc. (Issuer) CIK: 0001701541 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O BLACK DIAMOND THERAPEUTICS, INC. ONE MAIN STREET, 10TH FLOOR CAMBRIDGE MA 02142
Business Address
Buck Elizabeth (Reporting) CIK: 0001880385 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39200 | Film No.: 22648320